On this page
What is Thyroid Goiter?
Goiter (or struma) is any type of enlargement of the thyroid gland. This enlargement can take several forms:
- The presence of a solitary nodule or multiple nodules
- A uniform, diffuse increase in the volume of part or all of the gland
Anatomy of the Thyroid Gland
The thyroid is an endocrine gland located in the anterior (front) part of the neck, just below the Adam’s apple (thyroid cartilage of the larynx). It consists of two lobes connected by a central isthmus, giving it a characteristic butterfly shape. The thyroid’s functional cells, known as thyrocytes, produce the hormones T3 (triiodothyronine) and T4 (thyroxine). These hormones are released into the bloodstream and regulate the metabolic activity of nearly every cell in the body.
Thyroid function is primarily controlled by TSH (thyroid-stimulating hormone), secreted by the anterior pituitary gland (adenohypophysis), a small structure at the base of the brain. When thyroid hormone levels fall, the pituitary responds by releasing more TSH to stimulate the gland.
What Causes a Goiter?
In the majority of cases, goiter results from iodine deficiency in the diet. However, other important causes include:
- Exposure to environmental or drug-related goitrogens (substances that interfere with thyroid function)
- Genetic conditions affecting thyroid hormone synthesis
- Autoimmune
- Uncontrolled growth of thyroid cells (solitary nodules, multinodular goiter)
How Does a Goiter Present?
A goiter may be noticed by the patient as a visible swelling in the neck. In rare cases, a very large goiter can compress adjacent structures, causing difficulty swallowing or breathing difficulties.
In terms of thyroid function, the full spectrum of presentations is possible:
- Euthyroid goiter: a condition with normal thyroid function and no hormonal symptoms.
- Hypothyroidism: an underactive thyroid, which slows metabolism.
- Hyperthyroidism is an overactive thyroid condition, where the gland produces an excess of hormones.
Diagnostic Approach
To identify the underlying cause, the following are typically required in addition to clinical history and physical examination:
- Blood tests: TSH, free T3 (fT3), free T4 (fT4), thyroid antibodies, and urinary iodine levels
- Neck ultrasound to assess the structure of the gland
Treatment Overview
Treatment depends on the underlying cause and may include:
- Iodine supplementation in the diet
- Hormone replacement therapy with levothyroxine
- Radioiodine (radioactive iodine) ablation therapy
- Surgery (total or subtotal thyroidectomy, lobectomy, or nodule enucleation)
The overall prognosis is generally favorable when the cause is correctly identified and treated.
Causes
A wide range of conditions can trigger thyroid enlargement. Understanding the specific cause is essential for selecting the most appropriate treatment.
Iodine Deficiency
This is the most frequent cause worldwide. Iodine is an essential building block for the synthesis of thyroid hormones. When iodine intake is insufficient, T3 and T4 levels drop. The pituitary gland detects this and increases TSH secretion to stimulate the thyroid. However, instead of producing more hormones, the gland simply grows in size.
The result is a smooth, symmetrical, diffuse enlargement without nodules. When goiter affects more than 5% of a defined population in a geographic region, it is classified as endemic goiter. In non-endemic areas, it is called sporadic goiter.
Excess Iodine Intake
Paradoxically, too much iodine can also stimulate thyroid enlargement. This is seen, for example, in Japan, where high consumption of seaweed and fish provides exceptionally large amounts of iodine, which can overstimulate thyroid activity.
Genetic Defects in Thyroid Hormone Synthesis
Rare genetic mutations may impact proteins that play a role in any stage of T3 and T4 production. This includes everything from iodine uptake by thyrocytes to the final assembly of the hormones. When hormone output is impaired, TSH rises compensatorily, enlarging the gland.
Goitrogenic Medications
Certain drugs can induce goiter. The most notable example is chronic lithium therapy (used in bipolar disorder), as lithium’s chemical structure mimics iodine and interferes with thyroid hormone secretion.
Environmental Goitrogens
Some foods naturally contain substances that interfere with thyroid function and can promote goiter formation. These include:
- Cassava root (contains cyanogenic glycosides that block iodine uptake).
- Cruciferous vegetables like Brussels sprouts, cauliflower, and cabbage contain glucosinolates.
- Milk from regions where goitrogens are present in pasture grass
These foods are generally safe in typical dietary quantities but may be problematic in populations with marginal iodine intake.
Autoimmune Thyroid Diseases
- Graves’ disease: The immune system produces autoantibodies that mimic TSH, directly stimulating thyroid cell growth and hormone overproduction, causing a diffuse, toxic goiter with hyperthyroidism.
- Hashimoto’s thyroiditis: The immune system attacks the thyroid as if it were a foreign body. As thyrocyte function progressively declines, TSH rises to compensate, causing the gland to enlarge even as it becomes less functional.
Nodular Thyroid Disease
In some patients, thyroid growth is driven by uncontrolled, disorganized proliferation of thyroid cells, often associated with fibrosis. Nodules may be:
- Solitary or multiple (multinodular goiter)
- Benign (Plummer’s adenoma) or malignant (thyroid carcinoma)
- Functioning (secreting thyroid hormones autonomously) or non-functioning
Risk Factors
The probability of developing a goiter is higher in:
- Women compared to men
- Older individuals (risk increases progressively with age)
- People with a family history of thyroid disease
- Those with iodine deficiency or excess in their diet
- Individuals exposed to environmental goitrogens or goitrogenic medications
Symptoms
A goiter may be noticed by the patient as a visible or palpable enlargement of the neck, or it may be entirely subtle and discovered incidentally during a routine clinical examination.
Symptoms Related to Thyroid Function
Euthyroid (non-toxic) goiter: When thyroid function is preserved, the goiter produces no hormonal symptoms. This is the most common presentation.
Hypothyroidism symptoms (if thyroid function is insufficient):
- Fatigue and weakness (asthenia).
- Weight gain.
- Cold intolerance.
- Menstrual irregularities (oligomenorrhea).
- Myxedema: skin thickening and puffiness caused by the accumulation of mucopolysaccharides in the dermis.
- Constipation.
- Difficulty concentrating and memory problems.
- Depression.
Hyperthyroidism symptoms (in Graves’ disease or autonomous hormone-secreting nodules, also called toxic goiter):
- Agitation, anxiety, and restlessness.
- Unintentional weight loss.
- Increased appetite (hyperphagia).
- Heat intolerance and excessive sweating.
- Elevated pulse pressure (widened gap between systolic and diastolic blood pressure).
- Palpitations (cardiopalmus).
- Tremors.
- Diarrhea.
Symptoms Related to the Mass (Compressive Symptoms)
When the goiter is very large or contains areas of significant fibrosis, it may compress adjacent structures:
- Difficulty swallowing (dysphagia), which occurs due to esophageal compression
- Breathing difficulties (dyspnea), which result from tracheal narrowing
- Facial venous congestion, caused by compression of the neck veins
- Hoarseness, which results from compression of the recurrent laryngeal nerve (the branch of the vagus nerve that controls the vocal cord muscles)
Occasionally, pain and sudden swelling may occur due to spontaneous hemorrhage within a cyst or nodule.
Retrosternal Goiter
In approximately 10% of cases, a goiter extends downward into the mediastinum, the space between the lungs in the chest. This typically happens because an enlarged thyroid naturally migrates downward. More rarely, it occurs due to ectopic thyroid tissue. This is important because:
- It cannot be fully visualized by ultrasound alone
- It may obstruct blood vessels and nerves entering the chest
A classic sign is the Pemberton’s sign: when the patient raises both arms above their head, compression of the thoracic inlet by the goiter causes facial flushing, neck vein distension, and dizziness or syncope.
Prognosis and Complications
When correctly identified and treated, thyroid goiter has an overall good prognosis.
The most important concern is the possibility of malignancy. A thyroid nodule may represent a thyroid carcinoma, which should be suspected when:
- The nodule feels hard, irregular, and fixed to surrounding tissues on palpation
- There is a family history of thyroid cancer
- The patient has a history of radiation exposure to the neck or chest
Even when malignant, most thyroid cancers carry an excellent prognosis: overall 5-year survival is approximately 90%, reflecting the effectiveness of early diagnosis and treatment.
Compressive complications, particularly dysphagia and dyspnea, may require urgent surgical intervention if they severely impair the patient’s quality of life or safety.
Diagnosis
A thorough diagnostic workup integrates clinical assessment with laboratory and imaging findings.
Clinical Examination (History and Physical Exam)
The physician takes a detailed history, exploring:
- Dietary iodine intake (adequacy or excess)
- Family history of thyroid disease or thyroid cancer
- Current medications (diuretics, lithium, amiodarone, etc.)
- Symptoms of hypo- or hyperthyroidism
- Radiation exposure history
During physical examination, the physician stands behind the seated patient and palpates the anterior neck with fingertips, assessing the gland’s:
- Size and symmetry
- Consistency (soft, firm, or hard)
- Surface (smooth or nodular)
- Mobility with swallowing
The physician also palpates cervical lymph nodes, as lymph node enlargement may suggest malignancy.
Blood Tests
- Thyroid function panel: TSH, free T3 (fT3), and free T4 (fT4), which are the biologically active, unbound fractions of thyroid hormones.
- Thyroid antibodies:
- Anti-thyroid peroxidase (anti-TPO)
- Anti-thyroglobulin (anti-TG)
- Anti-TSH receptor (anti-rTSH / TRAb), which is specific for Graves’ disease
- Calcitonin: elevated in medullary thyroid carcinoma.
Urine Test
Urinary iodine concentration: Low levels of iodine in the urine support a diagnosis of iodine deficiency goiter.
Ultrasound (First-Line Imaging)
Ultrasound with color Doppler is the primary imaging modality for evaluating goiter. It provides detailed information on:
- Gland size, structure, and echogenicity
- Presence, number, and characteristics of nodules
- Vascularization (blood flow patterns)
Ultrasound also guides fine-needle aspiration (FNA) cytology or core needle biopsy when a nodule requires histological characterization to determine whether it is benign or malignant.
Advanced Imaging
- CT scan and MRI: Used less frequently; primarily indicated to map the precise extent of a large goiter and its relationship to surrounding structures, and essential for retrosternal or cervicomediastinal goiters where ultrasound cannot visualize the retrosternal component.
Thyroid Scintigraphy
In this nuclear medicine study, radioactive iodine is injected into the bloodstream and selectively concentrated by thyrocytes (which require iodine to produce hormones). The resulting scan reveals:
- Homogeneous uptake: This indicates normal thyroid function or a simple iodine-deficiency goiter.
- Heterogeneous uptake with multiple hot and cold areas, consistent with toxic multinodular goiter.
- Focal hot nodule with suppression of surrounding tissue: Plummer’s toxic adenoma.
- Cold (non-functioning) nodule: This requires a biopsy to exclude malignancy, although most cold nodules are benign.
Treatment
Treatment is tailored to the underlying cause of the goiter and its functional status.
Iodine-Deficiency Goiter (Endemic or Sporadic)
The primary treatment is dietary iodine supplementation. If hypothyroidism is also present, levothyroxine (synthetic T4) is initiated. After 3–6 months of therapy, significant regression of the goiter is typically observed.
Surgery (subtotal thyroidectomy) is rarely required, but may be indicated for:
- Tracheal compression
- Retrosternal goiter obstructing the thoracic inlet
- Cosmetic concerns or patient preference
Non-Toxic Multinodular Goiter
Treatment may be conservative, beginning with low-dose levothyroxine (typically 50 µg/day), gradually titrated while monitoring TSH. Radioiodine therapy at higher doses can induce selective destruction of overactive thyroid cells. Surgery is reserved for cases with acute compressive symptoms.
Toxic Multinodular Goiter
Initial management requires antithyroid medications (methimazole or propylthiouracil) combined with beta-blockers to control hyperthyroid symptoms. Definitive treatment is typically thyroidectomy, with radioiodine therapy as an alternative in selected patients.
Toxic Adenoma (Plummer’s Adenoma)
The treatment of choice is radioiodine therapy, which is highly effective because the radioiodine concentrates preferentially in the autonomous hyperfunctioning nodule while the suppressed surrounding thyroid tissue is spared. When surgery is chosen, it is limited to nodule enucleation or lobectomy (removal of one thyroid lobe).
Autoimmune Thyroid Diseases
- Hashimoto’s thyroiditis: Treatment is primarily hormone replacement with levothyroxine to correct hypothyroidism and reduce TSH-driven gland stimulation.
- Graves’ disease: Management depends on severity and may include:
- Antithyroid drugs (methimazole or propylthiouracil)
- Radioiodine ablation
- Total thyroidectomy (the definitive cure)
Thyroid Carcinoma
Given the malignant nature of the lesion, an aggressive surgical approach is required: total thyroidectomy, frequently combined with removal of involved cervical lymph nodes. Postoperative radioiodine therapy is administered in selected cases to eliminate residual thyroid tissue or metastases. Long-term follow-up with thyroglobulin monitoring and periodic imaging is essential.
Prevention
Preventing Iodine-Deficiency Goiter
The most effective prevention strategy is ensuring adequate dietary iodine intake. Good dietary sources of iodine include:
- Iodized salt, the cornerstone of public health iodine supplementation programs worldwide
- Fish and seafood
- Eggs
- Milk and dairy products
The World Health Organization (WHO) recommends 150 µg of iodine per day for adults, 250 µg for pregnant and breastfeeding women.
Avoiding Excess Stimulation
Excessive consumption of goitrogenic foods, particularly in individuals with borderline iodine intake, should be moderated:
- Cruciferous vegetables (cabbage, cauliflower, Brussels sprouts): safe in normal amounts when cooked, as heat partially inactivates goitrogenic compounds.
- Cassava root.
- Excessive seaweed consumption (can provide dangerously high iodine doses).
Early Detection and Treatment of Autoimmune Disease
Early diagnosis and appropriate management of Hashimoto’s thyroiditis and Graves’ disease are essential to prevent progressive thyroid enlargement and its associated complications. Regular thyroid function screening is recommended for individuals with a family history of thyroid disease or known autoimmune conditions.
References and Bibliography
- Jameson LJ, Weetman JL. Disorders of the Thyroid Gland. In: Harrison’s Principles of Internal Medicine, 18th edition. McGraw Hill Medical, New York, 2012.
- Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. The Lancet Diabetes & Endocrinology, Apr 2015. https://pubmed.ncbi.nlm.nih.gov/25591468/
- Di Marco A, Palazzo F. Goitre and thyroid cancer. In: Thyroid Disorders, Elsevier, 2017.
- World Health Organization (WHO). Iodine deficiency disorders. https://www.who.int/health-topics/iodine-deficiency-disorders
- American Thyroid Association (ATA). Goiter. https://www.thyroid.org/goiter/
- Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020
- Kahaly GJ, et al. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. European Thyroid Journal, 2018;7(4):167–186. https://doi.org/10.1159/000490384
- Garber JR, et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Thyroid, 2012;22(12):1200–1235. https://doi.org/10.1089/thy.2012.0205
